Global Information
회사소개 | 문의 | 위시리스트

추체간 케이지 : 의료기기 파이프라인 평가

Interbody Cages - Medical Devices Pipeline Assessment, 2019

리서치사 GlobalData
발행일 2019년 09월 상품 코드 595461
페이지 정보 영문 33 Pages
가격
US $ 2,500 ₩ 3,017,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 6,035,000 PDF by E-mail (Site License) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,500 ₩ 9,052,000 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


추체간 케이지 : 의료기기 파이프라인 평가 Interbody Cages - Medical Devices Pipeline Assessment, 2019
발행일 : 2019년 09월 페이지 정보 : 영문 33 Pages

세계 추체간 케이지(Interbody Cages) 시장의 주요 파이프라인 제품과 임상시험의 진행 상황에 대해 조사했으며, 제품 특성의 비교 분석, 주요 기업의 개요 및 대표적 제품, 최근 시장 동향 등의 정보를 정리하여 전해드립니다.

제1장 목차

제2장 서론

  • 추체간 케이지의 개요

제3장 현재 임상시험중인 제품

  • 파이프라인 제품 : 임상시험 단계별
  • 파이프라인 제품 : 영역별
  • 파이프라인 제품 : 규제 경로별
  • 파이프라인 제품 : 추정 인증 시기별

제4장 추체간 케이지 : 각 기업에서 현재 임상시험중인 파이프라인 제품

  • 추체간 케이지 기업 : 임상시험 단계별 파이프라인 제품
  • 추체간 케이지 : 임상시험 단계별 파이프라인 제품

제5장 추체간 케이지 기업·제품의 개요

  • Camber Spine Technologies LLC
  • Corelink, LLC
  • DePuy Synthes Inc
  • EIT Emerging Implant Technologies GmbH
  • Inion Oy
  • KISCO International
  • Maxigen Biotech Inc
  • Medyssey Co Ltd
  • Safe Orthopaedics SA
  • Spinal Balance Inc.
  • University of South Florida
  • Vivonics, Inc.

제6장 추체간 케이지 시장 : 최근 동향

제7장 부록

KSA 19.09.11

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

List of Tables

  • Table 1: Interbody Cages - Pipeline Products by Stage of Development
  • Table 2: Interbody Cages - Pipeline Products by Territory
  • Table 3: Interbody Cages - Pipeline Products by Regulatory Path
  • Table 4: Interbody Cages - Pipeline Products by Estimated Approval Date
  • Table 5: Interbody Cages Companies - Pipeline Products by Stage of Development
  • Table 6: Interbody Cages - Pipeline Products by Stage of Development
  • Table 7: Camber Spine Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: Corelink LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: EIT Emerging Implant Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: Inion Oy Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: KISCO International Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: Medyssey Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Safe Orthopaedics SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 40: Spinal Balance Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 43: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: Glossary

List of Figures

  • Figure 1: Interbody Cages - Pipeline Products by Stage of Development
  • Figure 2: Interbody Cages - Pipeline Products by Territory
  • Figure 3: Interbody Cages - Pipeline Products by Regulatory Path
  • Figure 4: Interbody Cages - Pipeline Products by Estimated Approval Date

GlobalData's Medical Devices sector report, "Interbody Cages - Medical Devices Pipeline Assessment, 2019" provides an overview of Interbody Cages currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Interbody Cages pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope:

  • Extensive coverage of the Interbody Cages under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Interbody Cages and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy:

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Interbody Cages under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Interbody Cages Overview

3. Products under Development

  • 3.1. Interbody Cages - Pipeline Products by Stage of Development
  • 3.2. Interbody Cages - Pipeline Products by Territory
  • 3.3. Interbody Cages - Pipeline Products by Regulatory Path
  • 3.4. Interbody Cages - Pipeline Products by Estimated Approval Date

4. Interbody Cages - Pipeline Products under Development by Companies

  • 4.1. Interbody Cages Companies - Pipeline Products by Stage of Development
  • 4.2. Interbody Cages - Pipeline Products by Stage of Development

5. Interbody Cages Companies and Product Overview

  • 5.1. Camber Spine Technologies LLC Company Overview
    • 5.1.1. Camber Spine Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Corelink LLC Company Overview
    • 5.2.1. Corelink LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. DePuy Synthes Inc Company Overview
    • 5.3.1. DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. EIT Emerging Implant Technologies GmbH Company Overview
    • 5.4.1. EIT Emerging Implant Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Inion Oy Company Overview
    • 5.5.1. Inion Oy Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. KISCO International Company Overview
    • 5.6.1. KISCO International Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Maxigen Biotech Inc Company Overview
    • 5.7.1. Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Medyssey Co Ltd Company Overview
    • 5.8.1. Medyssey Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Safe Orthopaedics SA Company Overview
    • 5.9.1. Safe Orthopaedics SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Spinal Balance Inc. Company Overview
    • 5.10.1. Spinal Balance Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. University of South Florida Company Overview
    • 5.11.1. University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Vivonics Inc Company Overview
    • 5.12.1. Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview

6. Interbody Cages- Recent Developments

  • 6.1. Mar 13, 2019: Kuros Biosciences receives US marketing clearance for intervertebral body fusion device
  • 6.2. Mar 12, 2019: joimax hosts international training summit to showcase innovative technologies
  • 6.3. Sep 24, 2018: Biedermann Motech to launch iMAS 360 procedure at NASS
  • 6.4. Sep 21, 2018: CoreLink surgical announces the launch of articulating expandable posterior lumbar system - FLXfit15

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer
Back to Top
전화 문의
F A Q